Current State of Advanced Biomaterials and Technologies in the Treatment of Peri-Implantitis: A Review of the Literature
Regeneration, Reconstruction & Restoration (Triple R),
Vol. 11 (2026),
11 July 2026,
https://doi.org/10.22037/rrr.v11.52124
Peri-implantitis remains a challenging biological complication in implant dentistry because predictable disease resolution requires infection control, implant surface decontamination, defect-based treatment planning, and long-term supportive care. Although conventional non-surgical, surgical, resective, and reconstructive approaches may improve selected clinical or radiographic outcomes, long-term stability remains difficult, particularly in advanced defects or around complex implant surfaces. This review of the literature summarizes the current state of advanced biomaterials and emerging technologies for peri-implantitis treatment, with emphasis on their mechanisms, clinical applications, limitations, translational relevance, and future perspectives. A focused literature search was performed in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar. Relevant studies and reviews were identified on peri-implantitis treatment, implant surface decontamination, reconstructive therapy, antimicrobial and bioactive biomaterials, nanoparticles, hydrogels, local drug-delivery systems, laser-assisted therapy, antimicrobial photodynamic therapy, air-abrasive decontamination, electrochemical approaches, cold atmospheric plasma, digital workflows, 3D printing, and artificial intelligence. The reviewed literature indicates that advanced biomaterial-based strategies and emerging technologies are best interpreted as adjunctive platforms rather than replacements for established treatment principles. Laser-assisted therapy, air-abrasive decontamination, and antimicrobial photodynamic therapy have accumulated the most clinical evidence among the reviewed adjunctive technologies, with reported short-term improvements in selected clinical or microbiological outcomes. In contrast, bioactive and antimicrobial membranes, nanoparticles, hydrogels, electrochemical methods, cold atmospheric plasma, and patient-specific 3D-printed scaffolds remain largely preclinical or early translational, with limited direct clinical evidence. Overall, these strategies may support peri-implantitis therapy, but their clinical readiness varies, and their use should remain cautious, adjunctive, and supported by standardized long-term clinical studies.